Precautions and safe management methods for discontinuation of avatrombopag (Sucoxin)

Avatrombopag is an oral thrombopoietic drug used primarily to treat thrombocytopenia or aplastic anemia associated with chronic liver disease. During drug withdrawal, patients need to pay special attention to changes in platelet levels. Because avatrombopag increases platelet counts by stimulating the bone marrow to produce platelets, abrupt discontinuation may cause a rapid drop in platelets and increase the risk of bleeding. Therefore, you should consult your doctor before stopping the drug and develop a gradual dose reduction or drug discontinuation plan based on platelet levels to avoid a rapid drop in platelets.

In actual practice, doctors usually gradually reduce the dosage of avatrombopag or extend the dosage interval to observe changes in platelets after the patient's platelet count stabilizes within a safe range. At the same time, before discontinuing medication, it is necessary to assess whether the patient has recent bleeding risks, such as surgery, dental operations, or trauma, and take preventive measures, such as platelet transfusions or delayed discontinuation of medication, if necessary, to ensure medication safety.

After discontinuation of the drug, patients should have their platelet count and coagulation function monitored regularly. It is usually recommended to conduct routine blood tests within one week, two weeks, and one month after stopping the drug to detect platelet decline or bleeding tendency in a timely manner. If the platelet level drops significantly or the patient develops bleeding symptoms, he should be followed up in time or resume medication according to the doctor's guidance to avoid serious bleeding events.

In addition, patients should pay attention to safe management in daily life during drug withdrawal, such as avoiding strenuous exercise, preventing trauma, using drugs that may affect platelet function (such as aspirin or anticoagulants) with caution, and maintaining good eating and rest habits. By strictly following the medication discontinuation plan and safety management measures guided by doctors, the risks associated with medication discontinuation can be effectively reduced and the continued safety and efficacy of treatment can be ensured.

Reference materials:https://www.drugs.com/